[CMS165v14] Controlling High Blood Pressure (MIPS 2026)

​

Measure Details

Percentage of patients 18-85 years of age who had a diagnosis of essential hypertension starting before and continuing into, or starting during the first six months of the measurement period, and whose most recent blood pressure was adequately controlled (<140/90mmHg) during the measurement period

​

Measure Parameters

​

Numerator

Patients whose blood pressure at the most recent visit is adequately controlled (systolic blood pressure < 140 mmHg and diastolic blood pressure < 90 mmHg) during the measurement period.

​

Denominator

Patients 18-85 years of age who had a visit and diagnosis of essential hypertension starting before and continuing into, or starting during the first six months of the measurement period.

​

Exclusions/Exceptions

• Exclude patients with evidence of end stage renal disease (ESRD), dialysis or renal transplant before or during the measurement period.
• Exclude patients with a diagnosis of pregnancy during the measurement period.
• Exclude patients who are in hospice care for any part of the measurement period.
• Exclude patients receiving palliative care during the measurement period.
• Patients 66 and older by the end of the measurement period who are living long term a nursing home any time on or before the end of the measurement period.
• Exclude patients 66-80 with an indication of frailty for any part of the measurement period who meet any of the following criteria:
  • Advanced illness diagnosis during the measurement period or the year prior
  • OR taking dementia medications during the measurement period or the year prior
• Exclude patients 81 and older with an indication of frailty for any part of the measurement period.

​

Elation Workflows

​

Documenting hypertension diagnosis in the patient’s chart

Patients must have an active diagnosis of hypertension recorded in their chart starting before and continuing into, or starting during the first six months of the measurement period. Elation looks for a hypertension ICD-10 code in either a visit note for the measurement period or in the Problem List. To add a hypertension diagnosis to the Problem List:

​

Documenting measure requirements using a Clinical Reminder in a visit note

This workflow is applicable if ALL of the following denominator requirements are met:

• Patient is between 18 to 85 years of age during the time of visit.
• Patient has an active diagnosis of hypertension either recorded:
  • in a visit note dated on or prior to June 30, 2026 OR
  • in the Problem List with a start date on or prior to June 30, 2026.

Clicking Dismiss will dismiss the reminder and the reminder will not appear again until a new visit note draft is opened.

​

Documenting exclusions/exceptions

Documenting frailty To document frailty in Elation using

1. Frailty diagnosis, advanced illness codes and/or medications
2. Add a frailty diagnosis to the Problem List. You must select from one of the frailty codes listed here.
3. Record one of the following:
4. an advanced illness diagnosis in 2 outpatient encounters using one of the codes listed here.
5. an advanced illness in 1 inpatient counter using one of the codes listed here.
6. a dementia medication in the patient’s chart.
7. A frailty device code
8. Click + Tag at the bottom of the visit note draft.
9. Create/add the appropriate document tag for the relevant frailty device from this list of frailty device codes.
10. If you are creating the document tag for the first time for a frailty device, make sure the document tag has the device’s HCPCS code listed.

​

Measure Information

High blood pressure (HBP) or hypertension, known as the silent killer, increases risks of heart disease and stroke which are two of the leading causes of death in the U.S. (Yoon, Fryar, & Carroll, 2015). A person who has HBP is four times more likely to die from a stroke and three times more likely to die from heart disease (CDC, 2012). The National Vital Statistics Systems reported that in 2014 there were approximately 73,300 deaths directly due to HBP and 410,624 deaths with any mention of HBP (CDC, 2014). Between 2006 and 2016 the number of deaths due to HBP rose by 46.3 percent (Benjamin et al, 2019). Managing and treating HBP would reduce cardiovascular disease mortality for males and females by 30.4 percent and 38.0 percent, respectively (Patel et al., 2015). The estimated annual average direct and indirect cost of HBP from 2014 to 2015 was $55.9 billion (Benjamin et al, 2019). Total direct costs of HBP is projected to increase to$220.9 billion by 2035 (Benjamin et al, 2019). A study on cost-effectiveness on treating hypertension found that controlling HBP in patients with cardiovascular disease and systolic blood pressures of >= 160 mm Hg could be effective and cost-saving (Moran, 2015). Many studies have shown that controlling high blood pressure reduces cardiovascular events and mortality. The Systolic Blood Pressure Intervention Trial (SPRINT) investigated the impact of obtaining a SBP goal of <120 mm Hg compared to a SBP goal of <140 mm Hg among patients 50 and older with established cardiovascular disease and found that the patients with the former goal had reduced cardiovascular events and mortality (SPRINT Research Group et al., 2015). Controlling HBP will significantly reduce the risks of cardiovascular disease mortality and lead to better health outcomes like reduction of heart attacks, stroke, and kidney disease (James et al., 2014). Thus, the relationship between the measure (control of hypertension) and the long-term clinical outcomes listed is well established. Reference: Measure Information from CMS

​

Attachments

• Advanced Illness Codes
• Frailty Codes
• Frailty Descriptions

​

Related Articles

• MIPS (2026) - Quality Category
• Clinical Quality Measures Reports Guide
• Clinical Reminders for Clinical Quality Measures
• Tag Reports and Notes with Document Tags
• MIPS (2026) Overview